Who is sponsoring NCT07359287?

NCT07359287 is sponsored by University Hospital, Caen.

What drugs are being tested in NCT07359287?

Interventions in NCT07359287: Antibiotic prescribing according to guidelines.

What condition does NCT07359287 study?

NCT07359287 studies Angina, Acute Bronchiolitis, Acute Bronchitis, COPD Exacerbation (AECOPD), Laryngitis, Acute Otitis Media (AOM), Serous or Congestive Otitis, Viral Respiratory Infection (e.g., Influenza), Community-Acquired Pneumonia (CAP), Rhinitis / Nasopharyngitis, Acute Sinusitis.

Is NCT07359287 still recruiting?

NCT07359287 is currently recruiting now. Last updated 22 January 2026.

Last reviewed 2026-01-22 · How we verify

NCT07359287: GRASP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

Recruiting now NA Last updated 22 January 2026

What this trial tests

NA trial testing Antibiotic prescribing according to guidelines in Angina in 4,500 participants. Currently enrolling.

Timeline

1 December 2025

Primary endpoint
1 June 2026

1 September 2026

Quick facts

Lead sponsor	University Hospital, Caen
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	4,500
Start date	1 December 2025
Primary completion	1 June 2026
Estimated completion	1 September 2026
Sites	1 location across France

Drugs / interventions tested

Antibiotic prescribing according to guidelines

Conditions studied

Angina — all drugs for Angina →
Acute Bronchiolitis — all drugs for Acute Bronchiolitis →
Acute Bronchitis — all drugs for Acute Bronchitis →
COPD Exacerbation (AECOPD) — all drugs for COPD Exacerbation (AECOPD) →

Sponsor

University Hospital, Caen

Who can join

Eligibility, any sex, with Angina or Acute Bronchiolitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Antimicrobial resistance (AMR), considered one of the greatest global threats by the WHO, justifies the development of initiatives to promote appropriate antibiotic use-especially in primary care, where most antibiotics in France are prescribed and where misuse remains common. We are proposing a cluster-randomized controlled trial to evaluate the effectiveness of a bimodal intervention combining: (1) improved communication about the circulation of respiratory viruses, and (2) strengthened collaborative practices between general practitioners and pharmacists through a multidisciplinary protocol aimed at verifying that prescribed treatment durations comply with guidelines. The study will include six primary care practices (24 physicians), with three practices in each study arm. The aim of this project is to assess whether the bimodal intervention can reduce the duration of antibiotic treatments for upper and lower respiratory tract infections. The first component (a "viral infection prescription" tool) focuses on reducing unnecessary treatment initiation, while the second (pharmacist-led review) aims to shorten excessive prescription durations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Angina

Currently open trials in the same condition.

NCT05786417 — LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions · Phase 4 · recruiting
NCT05634031 — Imaging Coronary Microvascular Dysfunction (CMD) Study · NA · recruiting

Other University Hospital, Caen trials

Trials by the same sponsor.

NCT07406737 — Feasibility and Outcomes Registry of Lumenless dEfibrillation Leads for Conduction System Pacing · not yet recruiting
NCT06639750 — Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell Transplantion · not yet recruiting
NCT07467031 — Bachstim Registry: a Feasability Study of Bachmann's Area Pacing · not yet recruiting
NCT07477132 — A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 · Phase 4 · not yet recruiting
NCT07520578 — EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WI · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07359287 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Caen
Last refreshed: 22 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07359287.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing